⌘K

Login Start Free

Home/Filings/4/0001140361-17-036061

4//SEC Filing

Naider Avi Z. 4

Accession 0001140361-17-036061

CIK 0001581720other

View on SEC.gov Company Profile

Filed

Sep 19, 8:00 PM ET

Accepted

Sep 20, 5:07 PM ET

Size

4.6 KB

Accession

0001140361-17-036061

Insider Transaction Report

Form 4

Period: 2017-09-18

Loxo Oncology, Inc.LOXO

Director

Transactions

Sale
Common Stock
2017-09-18$90.00/sh−5,000$450,000→ 149,118 total

Footnotes (1)

[F1]The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person.

Documents

1 file

4
doc1.xmlPrimary
FORM 4

Issuer

Loxo Oncology, Inc.

CIK 0001581720

Entity typeother

Related Parties

1

filerCIK 0001612217

Filing Metadata

Form type: 4
Filed: Sep 19, 8:00 PM ET
Accepted: Sep 20, 5:07 PM ET
Size: 4.6 KB

View on SEC.gov